Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

In-hospital resource utilization in surgical and transcatheter aortic valve replacement.

Reinöhl J, Kaier K, Gutmann A, Sorg S, von Zur Mühlen C, Siepe M, Baumbach H, Moser M, Geibel A, Zirlik A, Blanke P, Vach W, Beyersdorf F, Bode C, Zehender M.

BMC Cardiovasc Disord. 2015 Oct 22;15:132. doi: 10.1186/s12872-015-0118-x.

2.

Percutaneous management of vascular access in transfemoral transcatheter aortic valve implantation.

Dato I, Burzotta F, Trani C, Crea F, Ussia GP.

World J Cardiol. 2014 Aug 26;6(8):836-46. doi: 10.4330/wjc.v6.i8.836. Review.

3.

The evolution of cardiovascular surgery in elderly patient: a review of current options and outcomes.

Nicolini F, Agostinelli A, Vezzani A, Manca T, Benassi F, Molardi A, Gherli T.

Biomed Res Int. 2014;2014:736298. doi: 10.1155/2014/736298. Review.

4.

Functional status and quality of life after transcatheter aortic valve replacement: a systematic review.

Kim CA, Rasania SP, Afilalo J, Popma JJ, Lipsitz LA, Kim DH.

Ann Intern Med. 2014 Feb 18;160(4):243-54. Review.

5.

Systematic review and meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement for severe aortic stenosis.

Cao C, Ang SC, Indraratna P, Manganas C, Bannon P, Black D, Tian D, Yan TD.

Ann Cardiothorac Surg. 2013 Jan;2(1):10-23. doi: 10.3978/j.issn.2225-319X.2012.11.09.

6.

Patient selection for transcatheter aortic valve implantation: An interventional cardiology perspective.

Mylotte D, Martucci G, Piazza N.

Ann Cardiothorac Surg. 2012 Jul;1(2):206-15. doi: 10.3978/j.issn.2225-319X.2012.06.08.

7.

Transcatheter aortic valve implantation: The transfemoral versus the transapical approach.

Gaasch WH, D'Agostino RS.

Ann Cardiothorac Surg. 2012 Jul;1(2):200-5. doi: 10.3978/j.issn.2225-319X.2012.07.02. No abstract available.

8.

A systematic review of transapical aortic valve implantation.

Rahnavardi M, Santibanez J, Sian K, Yan TD.

Ann Cardiothorac Surg. 2012 Jul;1(2):116-28. doi: 10.3978/j.issn.2225-319X.2012.07.04.

9.

The next revolution: percutaneous aortic valve replacement.

Leon MB, Nikolsky E.

Rambam Maimonides Med J. 2010 Oct 31;1(2):e0016. doi: 10.5041/RMMJ.10016.

10.

A review of most relevant complications of transcatheter aortic valve implantation.

Neragi-Miandoab S, Michler RE.

ISRN Cardiol. 2013 May 12;2013:956252. doi: 10.1155/2013/956252.

11.

Comparison 30-day clinical complications between transfemoral versus transapical aortic valve replacement for aortic stenosis: a meta-analysis review.

Li X, Kong M, Jiang D, Dong A.

J Cardiothorac Surg. 2013 Jul 3;8:168. doi: 10.1186/1749-8090-8-168. Review.

12.

Prognostic utility of biomarkers in predicting of one-year outcomes in patients with aortic stenosis treated with transcatheter or surgical aortic valve implantation.

Parenica J, Nemec P, Tomandl J, Ondrasek J, Pavkova-Goldbergova M, Tretina M, Jarkovsky J, Littnerova S, Poloczek M, Pokorny P, Spinar J, Cermakova Z, Miklik R, Malik P, Pes O, Lipkova J, Tomandlova M, Kala P.

PLoS One. 2012;7(12):e48851. doi: 10.1371/journal.pone.0048851.

13.

Patient radiation exposure during transcatheter aortic valve replacement procedures.

Daneault B, Balter S, Kodali SK, Williams MR, Généreux P, Reiss GR, Paradis JM, Green P, Kirtane AJ, Smith C, Moses JW, Leon MB.

EuroIntervention. 2012 Oct;8(6):679-84. doi: 10.4244/EIJV8I6A106.

14.

The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience.

Puls M, Viel T, Danner BC, Jacobshagen C, Teucher N, Hanekop G, Schöndube F, Hasenfuss G, Seipelt RG, Schillinger W.

Clin Res Cardiol. 2012 Jul;101(7):553-63. doi: 10.1007/s00392-012-0426-4.

15.
16.

Changing nature of cardiac interventions in older adults.

Dodson JA, Maurer MS.

Aging health. 2011 Apr;7(2):283-295.

17.

ESC Working Group on Valvular Heart Disease Position Paper: assessing the risk of interventions in patients with valvular heart disease.

Rosenhek R, Iung B, Tornos P, Antunes MJ, Prendergast BD, Otto CM, Kappetein AP, Stepinska J, Kaden JJ, Naber CK, Acartürk E, Gohlke-Bärwolf C.

Eur Heart J. 2012 Apr;33(7):822-8, 828a, 828b. doi: 10.1093/eurheartj/ehr061.

18.

Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium.

Leon MB, Piazza N, Nikolsky E, Blackstone EH, Cutlip DE, Kappetein AP, Krucoff MW, Mack M, Mehran R, Miller C, Morel MA, Petersen J, Popma JJ, Takkenberg JJ, Vahanian A, van Es GA, Vranckx P, Webb JG, Windecker S, Serruys PW.

Eur Heart J. 2011 Jan;32(2):205-17. doi: 10.1093/eurheartj/ehq406.

19.

One year follow-up of the multi-centre European PARTNER transcatheter heart valve study.

Lefèvre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schächinger V, De Bruyne B, Eltchaninoff H, Thielmann M, Himbert D, Romano M, Serruys P, Wimmer-Greinecker G; PARTNER EU Investigator Group..

Eur Heart J. 2011 Jan;32(2):148-57. doi: 10.1093/eurheartj/ehq427.

Supplemental Content

Support Center